ASCP

Enable Biosciences Receives Accreditation From The College Of American Pathologists

Retrieved on: 
Tuesday, March 19, 2024
College, Risk, Patient, SAN, Accreditation, CAP, Laboratory, MD, Carolyn Bertozzi, ASCP, DPH, Health

SOUTH SAN FRANCISCO, Calif., March 19, 2024 /PRNewswire/ -- The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Enable Biosciences Clinical Reference Laboratory in South San Francisco, California, based on results of a recent on-site inspection as part of the CAP's Accreditation Programs.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., March 19, 2024 /PRNewswire/ -- The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Enable Biosciences Clinical Reference Laboratory in South San Francisco, California, based on results of a recent on-site inspection as part of the CAP's Accreditation Programs.
  • Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved patient outcomes.
  • Enable Biosciences is now among more than 8,000 CAP-accredited facilities worldwide.
  • "This accreditation underscores our commitment to providing the highest quality diagnostic services," said Lynette Sawyer, reflecting on the achievement.

Data Innovations Releases Lab GPS v2.1

Retrieved on: 
Wednesday, February 14, 2024
SSO, Google Play, Lab, IOS, App Store (iOS/iPadOS), ASCP, Apple Store, Instrument, Software as a service, Android, Health, LIS, Environment, Medical device

COLCHESTER, Vt., Feb. 14, 2024 /PRNewswire/ -- Data Innovations announces the availability of Lab GPS™ v2.1., which introduces a new mobile app and other enhancements to enterprise lab uptime monitoring and optimization through its truly vendor-neutral connectivity platform, Instrument Manager™ (IM). Lab GPS helps minimize costly clinical laboratory downtime and improve patient care by empowering laboratorians and IT administrators with all-in-one connectivity monitoring, notifications, and control.

Key Points: 
  • In this further development of Data Innovations' first cloud-hosted SaaS product, Lab GPS v2.1 enables LIS administrators to resolve connectivity issues faster by viewing and acting on issues from a mobile device.
  • Among the features of Lab GPS v2.1:
    As with the desktop version of Lab GPS, the mobile app allows LIS administrators to restart LIS and instrument connections remotely, thereby reducing lab downtime and improving patient care.
  • Lab GPS is only available to direct Data Innovations customers in the United States using Instrument Manager™ and is not available on business partner-sold systems.
  • More information on Lab GPS, including the ability to schedule a demo, can be found by clicking here .

KLAS Research Names Relatient Best in KLAS for Patient Self-scheduling

Retrieved on: 
Wednesday, February 7, 2024
Software, Practice Management, Telemedicine, Virtual Medicine, Health, Data Management, Health Technology, Technology, Other Health, ASCP, Feedback, MLS, Research, Patient, Dash, Plague, Health informatics, MBA, Tiffany Cross, Covenant Health, Organization, Retail

1 Best in KLAS patient self-scheduling solution by KLAS Research.

Key Points: 
  • 1 Best in KLAS patient self-scheduling solution by KLAS Research.
  • The Best in KLAS rankings are a direct result of feedback from thousands of providers throughout 2023.
  • 2024 marks the first year that KLAS has included the category of Patient Self-Scheduling in its rankings.
  • We’re thrilled to achieve this honor.”
    The Best in KLAS report is an annual award program recognizing software and service companies that excel in helping healthcare professionals improve patient care.

Midwest Transplant Network Surpasses Expectations to Save and Enhance Lives in 2023

Retrieved on: 
Monday, February 5, 2024
Partnership, Haematopoietic system, CCRN, DCU, ACHI, ASCP, Hospital, Patient, Transplant, MSN, Overmyer Network, OPO, Urinalysis, Hope, MTN, Eye, RN, Operating, Dentistry

“What we achieved at Midwest Transplant Network in 2023 reflects the commitment of the staff who do the work every day to support organ donation and transplantation.

Key Points: 
  • “What we achieved at Midwest Transplant Network in 2023 reflects the commitment of the staff who do the work every day to support organ donation and transplantation.
  • The work is hard, and happens in countless ways, but we are all dedicated to the mission of enhancing and saving lives through organ, eye and tissue donation” said Jan Finn, RN, MSN, President & CEO, Midwest Transplant Network.
  • The United Network for Organ Sharing reported that across the country, clinical workers performed more than 46,000 lifesaving transplants in 2023.
  • Incorporated in 1973, Midwest Transplant Network facilitates organ, eye and tissue donation in partnership with hospitals and other professional partners to give hope and share life.

Sharon Ward-Fore, MS, BS, MT(ASCP), CIC, FAPIC, honored with the Infection Control Today Educator of the Year Award™

Retrieved on: 
Tuesday, December 19, 2023
Online, Biology, Workforce, Multimedia, Microbiology, Infection, ASCP, Research, Disinfectant, ICT, IPS, Education, Heart, APIC, Love, CIC, IP, Nursing

Additionally, the individual must have done a superlative job in educating internal and external stakeholders about the importance of infection prevention.

Key Points: 
  • Additionally, the individual must have done a superlative job in educating internal and external stakeholders about the importance of infection prevention.
  • She started her career in an acute care hospital microbiology lab, then transitioned to industrial microbiology research and development.
  • Ward-Fore is an independent infection prevention consultant, a member of the editorial advisory board of the Infection Control Today journal, and a clinical editor for APIC Text Online.
  • Ward-Fore has a Bachelor of Science degree in biology and medical technology, a Master of Science degree in clinical microbiology, and is board-certified in infection control (CIC).

JP Kotha Appointed Vice President, Bioanalytical at Worldwide Clinical Trials

Retrieved on: 
Wednesday, November 29, 2023
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Foot, ASCP, Hematology, Patient, Multimedia, Worldwide, Automation, Therapy, Fine chemical, BioAnalyt, MBBS

Worldwide Clinical Trials (Worldwide), a leading global, full-service contract research organization (CRO), has appointed Jayaprakash (JP) Kotha , MBBS, Ph.D, ASCP (SH), as Vice President, Bioanalytical.

Key Points: 
  • Worldwide Clinical Trials (Worldwide), a leading global, full-service contract research organization (CRO), has appointed Jayaprakash (JP) Kotha , MBBS, Ph.D, ASCP (SH), as Vice President, Bioanalytical.
  • Kotha now leads lab operations and all activities in Worldwide’s Bioanalytical Center of Excellence , located in Austin, Texas.
  • View the full release here: https://www.businesswire.com/news/home/20231129451629/en/
    Worldwide Clinical Trials appoints Jayaprakash (JP) Kotha, MBBS, Ph.D, ASCP (SH), as Vice President, Bioanalytical.
  • “Worldwide is known for its specialized approach to bioanalytical services and clinical trials – one that prioritizes personalized partnerships and accessible technical expertise for its customers.

Breast Cancer Multiomics: Unified Insights in Tumor Heterogeneity, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, December 12, 2023
WGS, PST, ASCP, Whole genome sequencing, IDT, Gold, Disease, Breast cancer, Informatics, Transcriptome, Patient, CNV, Ductal carcinoma, MB, EST, Doctor of Philosophy, RNA-Seq, BioLegend, Cell, Vaccine

TORONTO, Dec. 12, 2023 /PRNewswire-PRWeb/ -- Discover an innovative webinar exploring a novel single-cell method for breast cancer multiomics, linking genetic variations, copy number changes and gene expressions with focused panels. While the information obtained from whole genome sequencing (WGS) studies is a clear gold standard for discovery-based sequencing, current sequencing costs and informatics challenges frequently diminish WGS usage. Instead, applications focus on exonic spaces, particularly druggable targets. The majority of these are small, focused panels — resulting in a significant resolution gap between comprehensive WGS and these focal panels.

Key Points: 
  • In this free webinar, explore a new method detailing genetic insights into breast cancer, enabling precise assessment of variations, gene expressions and targeted proteins at a single-cell level.
  • TORONTO, Dec. 12, 2023 /PRNewswire-PRWeb/ -- Discover an innovative webinar exploring a novel single-cell method for breast cancer multiomics, linking genetic variations, copy number changes and gene expressions with focused panels.
  • In this webinar, the featured speaker describes the utility of the IDT v2 exome hybrid capture after ResolveOME single-cell workflow in a cohort of cells derived from breast cancer patients.
  • Join this webinar to explore a new method detailing genetic insights into breast cancer, enabling precise assessment of variations, gene expressions and targeted proteins at a single-cell level.

LifeLabs and BCIT Collaborate to Launch Innovative Global Chapter on Blood Tests in Open Education Pathology Textbook

Retrieved on: 
Thursday, October 26, 2023
MLT, United Kingdom, Education, Pathology, UBC, BCIT, British Columbia Institute of Technology, ASCP, Medical laboratory scientist, Multimedia, Learning, Curriculum, Student, Provost, Blood, Textbook, Nursing

This new chapter, centred around blood and blood tests, offers an engaging and informative resource that transcends borders, benefiting healthcare professionals, students, and curious minds across the globe.

Key Points: 
  • This new chapter, centred around blood and blood tests, offers an engaging and informative resource that transcends borders, benefiting healthcare professionals, students, and curious minds across the globe.
  • "In our collaboration with BCIT, we've contributed to a resource that educates and inspires a diverse worldwide audience," said Charles Brown, President and CEO of LifeLabs.
  • “This new Open Education Pathology Textbook chapter exemplifies the strength of BCIT in working with industry to reduce barriers to education,” said Jennifer Figner, Provost and Vice President, Academic, BCIT.
  • This collaborative initiative between LifeLabs and BCIT provides a valuable resource for healthcare professionals and students while reinforcing the global impact of open education initiatives in the medical field.

The Alliance for Women's Health and Prevention Awards Inaugural Grant to ASCP to Examine Cervical Cancer Screening in Women from Diverse Populations in the U.S.

Retrieved on: 
Wednesday, October 18, 2023
Chairperson, Cervical cancer, Policy, Health, Government, History, Physician, Prevalence, ASCP, Infection, Research, Society, Disease, Quality, Woman, Patient, Birth control, Medical imaging, MD

CHICAGO and WASHINGTON, Oct. 18, 2023 /PRNewswire-PRWeb/ -- After years of seeing declining rates of cervical cancer in the United States, physicians are seeing an alarming increase in the number of advanced cervical cancer cases diagnosed. This is particularly true of Black and Hispanic women in lower socioeconomic backgrounds where they may not have access to adequate healthcare coverage, including regular screenings.

Key Points: 
  • This is particularly true of Black and Hispanic women in lower socioeconomic backgrounds where they may not have access to adequate healthcare coverage, including regular screenings.
  • "We are proud to be partnering with ASCP and investing in this important research, which we believe will help lay the groundwork for more comprehensive and equitable cervical cancer screening guidelines, and ultimately help save lives."
  • Sadly, most of these accelerating cases of advanced cervical cancer could have been prevented through regular screening.
  • The aggregated data will be analyzed to identify recent trends in cervical cancer and precancer detection rates in diverse populations, as well as other relevant clinical and socioeconomic factors available.

American Society for Clinical Pathology Awarded $631,983 Grant from the CDC to Strengthen the Laboratory Workforce

Retrieved on: 
Tuesday, September 26, 2023
Workforce, Learning, Medicine, Society, Joint Commission, Education, Building Bridges, Culture, Public, Marie Cassidy, American Society for Clinical Pathology, Pathology, Research, Strategic planning, Doctor of Philosophy, ASCP, CDC, Health, Global Health, MD, Laboratory, Master of Science, Korea Disease Control and Prevention Agency, SCT, Knowledge, Negotiation, Principal, USPS Building Bridges Special Postal Cancellation Series, Environment, News, Finance, Pharmaceutical industry, Nursing, Growth

CHICAGO, Sept. 26, 2023 /PRNewswire-PRWeb/ -- The American Society for Clinical Pathology (ASCP) has been awarded an additional $631,893 grant as part of a three-year grant from the Centers for Disease Control and Prevention (CDC) to strengthen the laboratory workforce in the United States. This multi-year grant, which began in September 2022, has allowed ASCP to respond to public health emergencies and foster the development of a quality- and patient-centric community of practice.

Key Points: 
  • CHICAGO, Sept. 26, 2023 /PRNewswire-PRWeb/ -- The American Society for Clinical Pathology (ASCP) has been awarded an additional $631,893 grant as part of a three-year grant from the Centers for Disease Control and Prevention (CDC) to strengthen the laboratory workforce in the United States.
  • ASCP CEO Blair Holladay, PhD, MASCP, SCT(ASCP)CM
    The Society has worked closely with the CDC to connect ASCP's universe of more than 250,000 pathologists and laboratory professionals to the CDC OneLab Network.
  • ASCP's involvement in the OneLab initiative is part of the Society's comprehensive strategies to address the medical laboratory workforce shortage."
  • Moving into the second year of this three-year grant, ASCP's efforts remain centered around strengthening the laboratory workforce, and maintaining our role as the go-to resource for laboratory advocacy.